“We Need to Deploy Them Very Thoughtfully and Carefully”: Perceptions of Analytical Treatment Interruptions in HIV Cure Research in the United States—A Qualitative InquiryKarine Dubé, Joseph D. Tucker, David Evans et al.|AIDS Research and Human Retroviruses|2017Cited by 70
Willingness to participate and take risks in HIV cure research: survey results from 400 people living with HIV in the USKarine Dubé, Sandra B. Greene, Laurie Sylla et al.|Journal of Virus Eradication|2017Cited by 67
'Well, It's the Risk of the Unknown… Right?': A Qualitative Study of Perceived Risks and Benefits of HIV Cure Research in the United StatesKarine Dubé, Sandra B. Greene, Jeff Taylor et al.|PLoS ONE|2017Cited by 66
Ethics of HIV cure research: an unfinished agendaKarine Dubé, Jeremy Sugarman, John Kanazawa et al.|BMC Medical Ethics|2021Cited by 47
Perceptions of Equipoise, Risk–Benefit Ratios, and “Otherwise Healthy Volunteers” in the Context of Early-Phase HIV Cure Research in the United States: A Qualitative InquiryKarine Dubé, Stuart Rennie, Lynda Dee et al.|Journal of Empirical Research on Human Research Ethics|2017Cited by 40